TU-7710
- Generic Name
- TU-7710
Study of TU7710 in Warfarin Anti-coagulated Healthy Male Subjects
Phase 1
Recruiting
- Conditions
- Hemophilia aHemophilia BBlood Coagulation Disorders
- Interventions
- Drug: Normal saline
- First Posted Date
- 2023-09-06
- Last Posted Date
- 2023-09-11
- Lead Sponsor
- TiumBio Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT06025552
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath